186 related articles for article (PubMed ID: 37593621)
21. The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer.
Zhao R; Wang W; Pan L; Lv X; He Y; Lian W; Ma Y; Zhang X; Yu R; Zhao S; Guo X; Huang T; Peng M
Front Oncol; 2023; 13():1047973. PubMed ID: 36845750
[TBL] [Abstract][Full Text] [Related]
22. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
Front Genet; 2022; 13():1001239. PubMed ID: 36425071
[No Abstract] [Full Text] [Related]
23. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
24. An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma.
Wu Y; Li K; Liang S; Lou X; Li Y; Xu D; Wu Y; Wang Y; Cui W
Respir Res; 2023 May; 24(1):142. PubMed ID: 37259066
[TBL] [Abstract][Full Text] [Related]
25. Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer.
Cao X; Zhou X; Chen C; Wang Z; Sun Q
Front Cell Dev Biol; 2022; 10():962389. PubMed ID: 36393842
[TBL] [Abstract][Full Text] [Related]
26. Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma.
Li Q; Tang Y; Wang T; Zhu J; Zhou Y; Shi J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):307-323. PubMed ID: 36575346
[TBL] [Abstract][Full Text] [Related]
27. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
Front Genet; 2021; 12():551605. PubMed ID: 33732281
[No Abstract] [Full Text] [Related]
28. Clinical significance and immune landscape of angiogenesis-related genes in bladder cancer.
Liu G; Zhang T; Gui D; Liu Q
Aging (Albany NY); 2023 Nov; 15(22):13118-13133. PubMed ID: 37988196
[TBL] [Abstract][Full Text] [Related]
29. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
Liu J; Shi Y; Zhang Y
EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
[TBL] [Abstract][Full Text] [Related]
30. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
31. Identification of immunogenic cell death-associated subtypes and characterization of the tumor microenvironment in endometrial cancer.
Pan F; Luo Y; Wang L; Cheng Y; Bu W; Zhao X; Xu Y; Chen L; Wang H
J Gene Med; 2023 Jul; 25(7):e3495. PubMed ID: 36894497
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma.
Han Y; Cai Q; Xie X; Gao S; Fan X
Front Oncol; 2022; 12():1011046. PubMed ID: 36419893
[TBL] [Abstract][Full Text] [Related]
33. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
Chen X; Hu G; Xiong L; Xu Q
Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
[No Abstract] [Full Text] [Related]
34. Construction of an immunogenic cell death-based risk score prognosis model in breast cancer.
Li Y; Feng J; Wang T; Li M; Zhang H; Rong Z; Cheng W; Duan Y; Chen Z; Hu A; Yu T; Zhang J; Shang Y; Zou Y; Ma F; Guo B
Front Genet; 2022; 13():1069921. PubMed ID: 36583019
[TBL] [Abstract][Full Text] [Related]
35. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
36. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis.
Liu Z; Luo Y; Su L; Hu X
Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760
[TBL] [Abstract][Full Text] [Related]
37. Identification of immunogenic cell death‑related prognostic signatures in pancreatic cancer.
Yu W; Li M; Xia J
Oncol Lett; 2023 Nov; 26(5):473. PubMed ID: 37809045
[TBL] [Abstract][Full Text] [Related]
38. A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response.
Tang X; Wang K; Yang J; Wang Y; Yan Z
Am J Cancer Res; 2024; 14(1):324-343. PubMed ID: 38323285
[TBL] [Abstract][Full Text] [Related]
39. Classification and clinical significance of immunogenic cell death-related genes in Plasmodium falciparum infection determined by integrated bioinformatics analysis and machine learning.
Zhang YH; Xie LH; Li J; Qi YW; Shi JJ
Malar J; 2024 Feb; 23(1):48. PubMed ID: 38360586
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
